Literature DB >> 11907011

Health related quality of life and health status in adult survivors with previously operated complex congenital heart disease.

M Kamphuis1, J Ottenkamp, H W Vliegen, T Vogels, K H Zwinderman, R P Kamphuis, S P Verloove-Vanhorick.   

Abstract

OBJECTIVE: To examine the impact of previously operated complex congenital heart disease on health related quality of life and subjective health status and to determine the relation between these parameters and physical status.
DESIGN: Cross sectional; information on medical follow up was sought retrospectively.
SETTING: Patients were randomly selected from the archives of the paediatric cardiology department, Leiden University Medical Centre, Leiden, The Netherlands, and approached irrespective of current cardiac care or hospital of follow up. PATIENTS: Seventy eight patients with previously operated complex congenital heart disease (now aged 18-32 years) were compared with the general population. MAIN OUTCOME MEASURES: Health related quality of life was determined with a specifically developed questionnaire (Netherlands Organisation for Applied Scientific Research Academic Medical Centre (TNO-AZL) adult quality of life (TAAQOL)) and subjective health status was assessed with the 36 item short form health survey (SF-36). Physical status was determined with the objective physical index, Somerville index, and New York Heart Association functional class.
RESULTS: Health related quality of life of the patients was significantly worse than that of the general population in the dimensions gross motor functioning and vitality (p < 0.01). Correlations between health related quality of life and physical status were poor. Patients had significantly worse subjective health status than the general population in the dimensions physical functioning, role functioning physical, vitality, and general health perceptions (p < 0.01). Correlations between subjective health status and physical indices were weak.
CONCLUSION: Adult survivors with previously operated complex congenital heart disease experienced limitations only in the physical dimensions of health related quality of life and subjective health status. Objectively measured medical variables were only weakly related to health related quality of life. These results indicate that, when evaluating health related quality of life, dedicated questionnaires such as the TAAQOL should be used.

Entities:  

Mesh:

Year:  2002        PMID: 11907011      PMCID: PMC1767074          DOI: 10.1136/heart.87.4.356

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  42 in total

1.  Importance of differentiating health status from quality of life.

Authors:  C Bradley
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

2.  Psychosocial profile of adults with complex congenital heart disease.

Authors:  T Horner; R Liberthson; M S Jellinek
Journal:  Mayo Clin Proc       Date:  2000-01       Impact factor: 7.616

3.  Quality of life and perceived health status in surviving adults with univentricular heart.

Authors:  Z Saliba; G Butera; D Bonnet; P Bonhoeffer; E Villain; J Kachaner; D Sidi; L Iserin
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

4.  Neurodevelopmental outcome and lifestyle assessment in school-aged and adolescent children with hypoplastic left heart syndrome.

Authors:  W T Mahle; R R Clancy; E M Moss; M Gerdes; D R Jobes; G Wernovsky
Journal:  Pediatrics       Date:  2000-05       Impact factor: 7.124

5.  Performance of the EuroQol in children with imperforate anus.

Authors:  E A Stolk; J J Busschbach; T Vogels
Journal:  Qual Life Res       Date:  2000-02       Impact factor: 4.147

6.  Exercise prescription in adults with congenital heart disease: a long way to go.

Authors:  L Swan; W S Hillis
Journal:  Heart       Date:  2000-06       Impact factor: 5.994

7.  Quality of life in children following mitral valve replacement.

Authors:  C van Doorn; R Yates; A Tunstill; M Elliott
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

8.  Randomised controlled trial of the effect of ventilation tubes (grommets) on quality of life at age 1-2 years.

Authors:  M M Rovers; P F Krabbe; H Straatman; K Ingels; G A Zielhuis
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

9.  Quality of life 20 and 30 years after surgery in patients operated on for tetralogy of Fallot and for atrial septal defect.

Authors:  B M Ternestedt; K Wall; H Oddsson; T Riesenfeld; I Groth; J Schollin
Journal:  Pediatr Cardiol       Date:  2001 Mar-Apr       Impact factor: 1.655

10.  Nomenclature and classification of congenital heart disease.

Authors:  M J Tynan; A E Becker; F J Macartney; M Q Jiménez; E A Shinebourne; R H Anderson
Journal:  Br Heart J       Date:  1979-05
View more
  29 in total

1.  The importance of socio-demographic factors for the quality of life of adults with congenital heart disease.

Authors:  Matthäus Vigl; Eva Niggemeyer; Alfred Hager; Gerda Schwedler; Siegfried Kropf; Ulrike Bauer
Journal:  Qual Life Res       Date:  2010-11-02       Impact factor: 4.147

Review 2.  Health-related quality of life in adults with tetralogy of Fallot repair: a systematic review and meta-analysis.

Authors:  Mahim Malik; Zaiba Shafik Dawood; Mahin Janjua; Sardar Shahmir Babar Chauhan; Laila Akbar Ladak
Journal:  Qual Life Res       Date:  2021-05-22       Impact factor: 4.147

3.  Clinical Profile and Quality of Life of Adult Patients After the Fontan Procedure.

Authors:  Giulia Bordin; Massimo Antonio Padalino; Sonja Perentaler; Biagio Castaldi; Nicola Maschietto; Pierantonio Michieli; Roberto Crepaz; Anna Chiara Frigo; Vladimiro Lorenzo Vida; Ornella Milanesi
Journal:  Pediatr Cardiol       Date:  2015-04-02       Impact factor: 1.655

4.  Is the severity of congenital heart disease associated with the quality of life and perceived health of adult patients?

Authors:  P Moons; K Van Deyk; S De Geest; M Gewillig; W Budts
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

5.  Psychosocial functioning of adults with congenital heart disease: outcomes of a 30-43 year longitudinal follow-up.

Authors:  Petra Opić; Jolien W Roos-Hesselink; Judith A A Cuypers; Maarten Witsenburg; Annemien van den Bosch; Ron T van Domburg; Ad J J C Bogers; Elisabeth M W J Utens
Journal:  Clin Res Cardiol       Date:  2014-12-07       Impact factor: 5.460

6.  Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial.

Authors:  Meletios A Dimopoulos; Michel Delforge; Roman Hájek; Martin Kropff; Maria T Petrucci; Philip Lewis; Annabel Nixon; Jingshan Zhang; Jay Mei; Antonio Palumbo
Journal:  Haematologica       Date:  2012-12-14       Impact factor: 9.941

7.  Surviving meningococcal septic shock in childhood: long-term overall outcome and the effect on health-related quality of life.

Authors:  Corinne M P Buysse; Lindy C A C Vermunt; Hein Raat; Jan A Hazelzet; Wim C J Hop; Elisabeth M W J Utens; Koen F M Joosten
Journal:  Crit Care       Date:  2010-06-29       Impact factor: 9.097

8.  Quality of Life is Diminished in Patients with Tetralogy of Fallot with Mild Residual Disease: A Comparison of Tetralogy of Fallot and Isolated Valvar Pulmonary Stenosis.

Authors:  Shivani M Bhatt; Elizabeth Goldmuntz; Amy Cassedy; Bradley S Marino; Laura Mercer-Rosa
Journal:  Pediatr Cardiol       Date:  2017-08-31       Impact factor: 1.655

9.  Interpretation bias for heart sensations in congenital heart disease and its relation to quality of life.

Authors:  Petra A Karsdorp; Merel Kindt; Simon Rietveld; Walter Everaerd; Barbara J M Mulder
Journal:  Int J Behav Med       Date:  2008

10.  Measuring health-related quality of life in Hungarian children attending a cardiology clinic with the Pediatric Quality of Life Inventory.

Authors:  Andrea Berkes; James W Varni; István Pataki; László Kardos; Csilla Kemény; Gábor Mogyorósy
Journal:  Eur J Pediatr       Date:  2009-09-19       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.